Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mulberry extract refers to an extract derived from the leaves or fruit of the mulberry tree, primarily from species such as Morus alba (white mulberry) and Morus nigra (black mulberry). It is used as a dietary supplement or herbal remedy and is promoted for its hypoglycemic, antioxidant, anti-inflammatory, and immunomodulatory effects. In animal and in vitro studies, mulberry leaf extract has demonstrated the ability to lower blood glucose by improving glucose metabolism, increasing insulin secretion, and inhibiting digestive enzymes such as alpha-glucosidase, which are responsible for carbohydrate breakdown and absorption[1][2][3]. Its high antioxidant content also provides cellular protection from oxidative stress and free radical injury, which may confer benefits in metabolic and radiation-induced damage settings[1][2][3]. Some evidence also supports its use for cardiovascular health, antibacterial effects, and as an adjunct in cancer radiotherapy for its tissue-protective actions[2][3]. Human data is limited, and approval status varies by region; in India, it is classified as an approved herbal supplement[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mulberry extract.